Medications

FDA approves Itvisma for spinal muscular atrophy

The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...

Neuroscience

AI supports home-based balance training

Balance training patients may soon be able to get AI feedback during home exercises, with four wearable sensors and a new machine learning model developed at the University of Michigan.

Gerontology & Geriatrics

An innovative tool helps measure healthy aging

A Florida State University researcher is part of a pioneering team that has developed a new measure to understand and support healthy aging, with the potential to change how health care workers, employers and policymakers ...

Addiction

Report reveals scale of alcohol's harm to others

A landmark report led by La Trobe University has unveiled the true scale of damage caused by alcohol in Australia. "Alcohol's Harm to Others in Australia: Patterns, Costs, Disparities and Precipitants" was compiled over six ...

page 40 from 40